FEBS PRESS

FEBS Press is pleased to welcome its fourth journal, Molecular Oncology, to this platform. Molecular Oncology is now fully Open Access and all content from the past 10 years is now available for all to read. The publication of high-quality journals by scientists for scientists is one the core objectives of The Federation of European Biochemical Societies (FEBS), with the revenue raised supporting fellowships, courses, congresses and other activities.

Journals Toggle

The FEBS Journal For high-quality full-length papers and reviews, with particular focus on biochemistry, molecular biology, structural biology and cell biology.
FEBS Letters For highly significant research letters that merit urgent publication, as well as timely reviews of wide interest in the molecular biosciences.
Molecular OncologyFor high-impact discoveries, approaches and technical advances in basic, clinical and discovery-driven translational cancer research.
FEBS Open Bio For rapid open access publication of scientifically sound research articles in the molecular and cellular life sciences.

Highlighted Articles

The dock-and-coalesce mechanism for the association of a WASP disordered region with the Cdc42 GTPase

Zhou and colleagues, The FEBS Journal

Intrinsically disordered proteins (IDPs) undergo folding upon binding to their interacting partners. Using the Wiskott-Aldrich Syndrome protein (WASP) and its binding partner, the Cdc42 GTPase, Zhou and colleagues show that binding begins with diffusion-dependent docking between the intrinsically disordered GTPase-binding domain (GBD) of WASP and its cognate binding site on Cdc42, and subsequently the remaining segments of WASP coalesce around their Cdc42 subsites. The authors also show that the rate of the docking step is the main contributor to the association rate constant of this two-step binding process.



Focal adhesions: a personal perspective on a half century of progress

Burridge, The FEBS Journal

Focal adhesions are sites of interaction between the actin cytoskeleton and the extracellular matrix mediated by clustered integrin receptors on the plasma membrane. In this Discovery-in-Context Review, Keith Burridge provides a personal account on the development of the field of focal adhesion research, beginning with the initial description of focal adhesions almost 50 years ago, to the identification of the structural components of focal adhesions and their role in many signalling pathways.



Lang

hSnd2 protein represents an alternative targeting factor to the endoplasmic reticulum in human cells

Lang, S. and colleagues, FEBS Letters

The SRP (signal recognition particle) and GET (guided entry of tail-anchored proteins) pathways target proteins to the endoplasmic reticulum (ER). Another ER-targeting pathway, SRP-independent (SND), has been identified in yeast. Here, the authors present the first functional characterization of a human SND pathway component, hSND2.  An ER membrane protein, hSnd2 preferentially targets proteins with a C-terminal transmembrane domain. The study provides insights into distinct and overlapping functions of the ER-targeting routes.



Teis and colleagues

Dissecting the structure-function relationship in lysozyme domain of mycobacteriophage D29-encoded peptidoglycan hydrolase

Jain, V. and colleagues, FEBS Letters

Bacteriophage lysins degrade bacterial cell wall peptidoglycans during virion release. Here, Joshi et al. characterize the central lysozyme domain of Mycobacteriophage D29 Lysin A, which can hydrolyze peptidoglycans of both Gram-positive and Gram-negative bacteria. The authors map the active site and identify critical residues conferring stability and functionality. The results might enable the development of mycobacteriophage-based broad-spectrum antibacterials.



Indoxyl sulfate

A uremic toxin (indoxyl sulfate) found in chronic kidney disease supresses bone formation and resorption

Inada and colleagues, FEBS Open Bio

Patients with chronic kidney disease (CKD) often present with bone turnover abnormalities, which has been associated with low serum levels of parathyroid hormone (PTH). Here, Inada and colleagues report that Indoxyl sulphate (IS), a uremic toxin known to accumulate in the blood of CKD patients, directly supresses osteoblast/osteoclast coupling and bone formation in vitro. This, combined with their previous findings that showed IS exacerbated low bone turnover induced by parathyroidectomy suggests that IS directly induces low bone turnover via the inhibition of bone formation using mechanisms separate from skeletal resistance to parathyroid hormone (PTH). This suggests IS initiates low-turnover bone disease in patients with CKD via a direct action upon both osteoclast precursors and osteoblasts to supress bone formation and resorption.



Dovitinib

Dovitinib enhances temozolomide efficacy in glioblastoma cells

Hombach-Klonisch and colleagues, Molecular Oncology

Dovitinib (Dov), an FDA- approved oral drug, is able to cross the blood-brain barrier and has recently demonstrated promising efficacy in clinical trials for glioblastoma (GB) patients with recurrent disease. The Dov-mediated molecular mechanisms in GB cells remained unknown. Here, Hombach-Klonisch and colleagues show that Dov treatment attenuated the STAT3/LIN28/Let-7/HMGA2 regulatory axis in GB cells, and downregulated key base excision repair factors known to repair temozolomide (TMZ) induced DNA damage. Dual or sequential treatment with Dov and TMZ enhanced the efficacy of TMZ, reduced GB cell survival, growth, and self-renewal capacity and severely compromised the recovery of GB cells. Alternate administration of Dov and TMZ may improve therapeutic efficacy, especially in patients expected to exhibit increased TMZ resistance. These findings suggest ‘Dov priming’ is an encouraging novel therapeutic strategy to improve the efficacy of TMZ in patients with GB.



About FEBS Press

News about FEBS Press

In recognition of Lung Cancer Awareness Month, the FEBS Press have created a collection of articles on the topic.
Three FEBS Press journals – The FEBS Journal, FEBS Letters and FEBS Open Bio – award poster prizes at scientific meetings
A virtual issue from The FEBS Journal, FEBS Letters and FEBS Open Bio on the molecular coordinates of the circadian clock...

FEBS Open Bio is celebrating its 5th anniversary - take a look at their new Virtual Issues showcasing content in Cancer biology, Microbiology, Plant Biology, and Computational and Systems Biology

NobelRead the celebratory FEBS Letters Virtual Issue "Autophagy: The 2016 Nobel Prize" collecting studies by Yoshinori Ohsumi and his coworkers


This Virtual Issue showcases specially selected articles from the FEBS Press journals - The FEBS Journal, FEBS Letters and FEBS Open Bio - published in 2016

About FEBS

  • FEBS
  • FEBS Advanced Courses
  • FEBS Fellowships
  • FEBS Awards
  • FEBS Congress 2018
  • FEBS Congress 2018

    News about FEBS

    FEBS Workshop on breast cancer research
    A meeting to bring together basic researchers, clinicians and translational scientists. Registration is open...


    FEBS Special Meeting on ATP-binding cassette (ABC) proteins
    Explore the speaker line up for this event in Innsbruck. Registration has opened...


    FEBS Anniversary Prizes 2017Just announced – FEBS Anniversary Prizes 2017
    These prizes honour young senior researchers invited to speak at a FEBS Congress...